Skip to main content

Drug Abuse Testing Market Size Analysis By Test Type, Samples, New Methods, Technology and Demand Overview

Drug Abuse Testing Industry Highlights 2019
The growing use of illicit drugs all over the world and the growing awareness about drug of abuse testing are the major drivers for the global drugs of abuse testing market. Due to the growing number of youths becoming addicted to illegal substances, many governments around the world have come up with strong anti-drugs policies. Strict enforcement of drug monitoring policies is being practiced in most countries around the world. This has led to a growing demand for drugs of abuse testing equipment. This is likely to remain the major driver for the global drug of abuse testing market over the forecast period due to the increasing government efforts to fight growing drug usage.
Leading players in the global drug of abuse testing Industry include -
Quest Diagnostics
Thermo Fisher Scientific Inc.
LabCorp
F. Hoffman-La Roche Ltd.
Abbott Laboratories
Sonic Healthcare
Randox Laboratories
Bio-Rad Laboratories Inc
and Others
Technological refinement of small, portable drug of abuse testing devices is likely to be a major target for players in the global drug of abuse testing market over the forecast period. Parents are becoming increasingly concerned about illegal drug use by their wards, which has led to a growing demand for home-based testing for drugs. Drug of abuse testing equipment indicates whether drugs have been consumed within a specific timeframe, but they are not very good at revealing addiction patterns. This is likely to be a key restraint against the global drugs of abuse testing market over the forecast period.
drug of abuse testing Industry Segmentation:
The global drug of abuse testing market is segmented on the basis of test type and sample type.
By test type, the global drug of abuse testing market is segmented into laboratory drug testing and onsite screening tests. Onsite screening tests comprise the dominant segment due to the higher convenience and cost-effectiveness of onsite screening. The onsite screening tests segment held a dominant 71.62% share in the market in 2018.
On the basis of sample type, the drug of abuse testing market is segmented into urine, hair, saliva and others. Urine holds a majority share in the global drug of abuse testing market, as urine contains metabolites from several types of drugs. Saliva is the second most popular sample type in the drug of abuse testing market.
The global "drugs of abuse testing market is expected to grow at a CAGR of 5.33% over the forecast period from 2019 to 2025", according to a new research report from Market Research Future (MRFR). 
3.1 Introduction
3.1.1 International Drug Trafficking
3.1.2 Drug Trafficking and Illicit Drug Use in North America
3.1.3 Drug Trafficking and Illicit Drug Use in Europe
3.1.4 Drug Trafficking and Illicit Drug Use in Asia-Pacific
3.2 Technology Analysis – Drug Abuse Testing Market
3.2.1 Chromatography Technology
3.2.2 Immunoassay Technology
3.3 Single vis-à-vis Multiple Parameter Test
3.4 Factors Driving the Market and its Impact on Market Forecast
3.4.1 Increased Use of Drug Testing at Organizational Level
3.4.2 Increased Production and Trade of Illicit Drugs Worldwide
3.4.3 Global Increase in Road Accidents and Death Rates
3.4.4 Increase in the Consumption of Illegal Drugs
3.4.5 Impact Analysis of Drivers on Market Forecast
3.5 Factors Hindering the Market and its Impact on Market Forecast
3.5.1 Legalization of Drugs
3.5.2 Social Issues Associated with Drug Abuse Testing
3.5.3 Inability of Testing Products to Detect Low-Dose Designer Drugs
3.5.4 Impact Analysis of Restraints on Market Forecast
Access Complete Premium Reserarch Details at: https://www.marketresearchfuture.com/reports/drug-abuse-testing-market-1930 
drug of abuse testing Industry Size Regional Analysis:
The global drug of abuse testing market is segmented by region into North America, Europe, Asia Pacific, and rest of the world.
North America is the dominant revenue generator in the global drug of abuse testing market. The U.S. is the top consumer of drug of abuse testing devices and is likely to retain the position over the forecast period due to the strict enforcement of anti-drug legislation in the country. Awareness among parents about drug use among teenagers is also increasing, which is likely to be a key driver for the drug of abuse testing market in the U.S.
About Market Research Future: Our team have supreme objective to provide the optimum quality market research and intelligence services to our clients. market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more